An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone shared that they’re injecting two peptides — KPV and GHK-Cu — using two small vials, and they described a personal dosing plan that ramps the injections up over several weeks and that they just did their first shot in the belly. That’s the basic news: it’s a self-administered, at-home peptide routine, not a clinical trial or doctor-supervised program. KPV is a short chain of three amino acids (think of amino acids as the building blocks of proteins). It’s being looked at mainly for reducing inflammation and possibly helping with wound healing. GHK-Cu (often written GHK‑Cu) is another small peptide that naturally occurs in the body and binds copper; researchers have studied it for skin repair, collagen stimulation, and anti‑inflammatory effects. Both are sometimes used in cosmetics or experimental therapies, but that doesn’t mean they’re approved drugs for all uses. The message you saw is just one person’s protocol, not a published study. It lists vial concentrations and a step-up dosing schedule — for example, KPV vial labeled 3 ml = 10 mg and a plan of 6 units the first week, 9 units the next, and so on; GHK‑Cu vial labeled 5 ml = 50 mg and a plan of 15 units the first two weeks then 20 units. There’s no information about clinical outcomes, safety monitoring, or results. In other words, this is anecdote — a single person sharing what they’re doing — not evidence that these doses work or are safe for others. Why people care: both peptides are touted online for helping with skin health, healing, and inflammation. For someone trying to treat a chronic skin issue, scar, or slow‑healing wound, self‑administered peptides can feel hopeful because they’re relatively easy to inject and many users report improvements. But because these posts don’t come with objective measurements or medical oversight, they don’t prove effectiveness. They mainly show what one person chose to try. Caveats and risks are important. Injecting any substance carries infection risk if not done cleanly, and self‑dosing can lead to incorrect amounts. The safety profiles of KPV and GHK‑Cu aren’t fully established for routine injections in people, and regulatory agencies may not approve them for these uses. Allergic reactions, skin irritation, or unexpected systemic effects are possible. If someone is pregnant, breastfeeding, has immune problems, or takes medications, they should be cautious. The safest route is to talk with a healthcare professional before starting such a regimen, and to prefer treatments that have been tested in controlled studies. Bottom line: this is a personal, at‑home peptide experiment, not scientific proof; it might sound promising, but it carries real risks and limited evidence, so consult a clinician before trying it.
Source: r/Peptides